Horita Masahiro, Nishida Keiichiro, Hashizume Kenzo, Sugimoto Yoshihisa, Nasu Yoshihisa, Nakahara Ryuichi, Harada Ryozo, Ozaki Toshifumi
Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Acta Med Okayama. 2019 Jun;73(3):235-240. doi: 10.18926/AMO/56866.
We investigated the prevalence of and risk factors for the progression of upper cervical lesions (UCLs) in patients with rheumatoid arthritis (RA). A retrospective analysis of 49 patients with RA (4 males, 45 females) was conducted. The UCLs included atlanto-axial subluxation and vertical subluxation. We investigated the clinical factors including the Disease Activity Score 28 based on C-reactive protein (DAS28-CRP) and the modified Health Assessment Questionnaire-Disability Index as well as radiographic changes between the baseline (at May 2010 to April 2013) and final follow-up. Forty patients (81.6%) were classified as the non-progressive group, and the other 9 patients (18.4%) comprised the progressive group. The progressive group's final CRP values, baseline or final MMP-3 levels, DAS28-CRP, and rate of pre-existing lesions at baseline were all significantly higher than those of the non-progressive group (p=0.017, p=0.043, p=0.002, p=0.008, p<0.001, and p=0.008 respectively). A multivariate logistic regression analysis demonstrated that DAS28-CRP at baseline was a risk factor for radiographic progression (p=0.018, odds ratio: 2.54, 95% confidence interval: 1.17-5.51). Our findings indicate that higher disease activity might influence the progression of UCLs in patients with RA.
我们调查了类风湿关节炎(RA)患者上颈椎病变(UCLs)的患病率及病情进展的危险因素。对49例RA患者(4例男性,45例女性)进行了回顾性分析。UCLs包括寰枢椎半脱位和垂直半脱位。我们调查了包括基于C反应蛋白的28关节疾病活动评分(DAS28-CRP)、改良健康评估问卷残疾指数等临床因素,以及基线期(2010年5月至2013年4月)与最终随访之间的影像学变化。40例患者(81.6%)被归类为非进展组,另外9例患者(18.4%)为进展组。进展组的最终C反应蛋白值、基线或最终基质金属蛋白酶-3水平、DAS28-CRP以及基线期既往病变发生率均显著高于非进展组(分别为p = 0.017、p = 0.043、p = 0.002、p = 0.008、p < 0.001和p = 0.008)。多因素逻辑回归分析表明,基线期DAS28-CRP是影像学进展的危险因素(p = 0.018,比值比:2.54,95%置信区间:1.17 - 5.51)。我们的研究结果表明,较高的疾病活动度可能会影响RA患者UCLs的病情进展。